Orphazyme has dismissed co-founder and chief scientific officer

Thomas Kirkegaard Jensen is no longer a part of biotech company Orphazyme, which he helped found in 2009. According to CEO Anders Vadsholt, it’s been necessary to make prioritizations, a sentiment that is met by understanding from the departing co-founder.

Thomas Kirkegaard Jensen, a co-founder of Orphazyme, has been let go in the company's latest round of job cuts | Photo: Orphazyme / PR

Thomas Kirkegaard Jensen is no longer a part of the biotech company he helped found more than a decade ago, he informs MedWatch.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs